TR199900191T2 - (S)-3,4-Dihidroksibutirik asitin korumal� esterlerinin sentezi i�in geli�tirilmi� proses. - Google Patents
(S)-3,4-Dihidroksibutirik asitin korumal� esterlerinin sentezi i�in geli�tirilmi� proses.Info
- Publication number
- TR199900191T2 TR199900191T2 TR1999/00191T TR9900191T TR199900191T2 TR 199900191 T2 TR199900191 T2 TR 199900191T2 TR 1999/00191 T TR1999/00191 T TR 1999/00191T TR 9900191 T TR9900191 T TR 9900191T TR 199900191 T2 TR199900191 T2 TR 199900191T2
- Authority
- TR
- Turkey
- Prior art keywords
- improved process
- synthesis
- dihydroxybutyric acid
- esters
- protected esters
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- DZAIOXUZHHTJKN-VKHMYHEASA-N 3S,4-dihydroxy-butyric acid Chemical compound OC[C@@H](O)CC(O)=O DZAIOXUZHHTJKN-VKHMYHEASA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- FUDDLSHBRSNCBV-VKHMYHEASA-N (4s)-4-hydroxyoxolan-2-one Chemical compound O[C@@H]1COC(=O)C1 FUDDLSHBRSNCBV-VKHMYHEASA-N 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 150000002905 orthoesters Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2236996P | 1996-07-29 | 1996-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199900191T2 true TR199900191T2 (xx) | 1999-04-21 |
Family
ID=21809241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/00191T TR199900191T2 (xx) | 1996-07-29 | 1997-07-01 | (S)-3,4-Dihidroksibutirik asitin korumal� esterlerinin sentezi i�in geli�tirilmi� proses. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5998633A (enExample) |
| EP (1) | EP0915866B1 (enExample) |
| JP (1) | JP2000515882A (enExample) |
| KR (1) | KR100447370B1 (enExample) |
| CN (1) | CN1093126C (enExample) |
| AT (1) | ATE215078T1 (enExample) |
| AU (1) | AU3515497A (enExample) |
| CO (1) | CO4950542A1 (enExample) |
| DE (1) | DE69711391T2 (enExample) |
| DK (1) | DK0915866T3 (enExample) |
| ES (1) | ES2176756T3 (enExample) |
| HU (1) | HU226465B1 (enExample) |
| IL (1) | IL127058A (enExample) |
| PT (1) | PT915866E (enExample) |
| TR (1) | TR199900191T2 (enExample) |
| WO (1) | WO1998004543A1 (enExample) |
| ZA (1) | ZA976705B (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69711391T2 (de) * | 1996-07-29 | 2002-11-07 | Warner-Lambert Co., Morris Plains | Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern |
| CN1166781C (zh) * | 1998-07-24 | 2004-09-15 | 三星精密化学株式会社 | 制备光学纯(S)-3-羟基-γ-丁内酯的连续方法 |
| KR100332703B1 (ko) * | 1998-07-24 | 2002-08-27 | 삼성정밀화학 주식회사 | 광학활성을갖는(s)-3,4-에폭시부티르산염의제조방법 |
| US6713290B2 (en) | 1998-07-24 | 2004-03-30 | Samsung Fine Chemicals Co., Ltd. | Process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone |
| US6235930B1 (en) * | 1999-03-31 | 2001-05-22 | Board Of Trustees Operating Michigan State University | Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars |
| HU227840B1 (en) * | 1999-05-06 | 2012-05-02 | Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag | Intermediates of atorvastatin synthesis and process for producing them |
| IL149087A0 (en) | 1999-12-17 | 2002-11-10 | Warner Lambert Res & Dev Ie | A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium |
| AU780247B2 (en) * | 1999-12-17 | 2005-03-10 | Pfizer Science And Technology Ireland Limited | A process for producing crystalline atorvastatin calcium |
| JP4598917B2 (ja) * | 2000-04-28 | 2010-12-15 | ダイセル化学工業株式会社 | ラクトンの製造方法 |
| KR100645665B1 (ko) | 2000-07-27 | 2006-11-13 | 에스케이 주식회사 | (ｓ)-베타-하이드록시-감마-부티로락톤의 연속 제조방법 |
| EP1734034A3 (en) | 2001-01-09 | 2007-01-03 | Warner-Lambert Company LLC | Carboxylic acid salts of beta-alanine esters or -amides |
| US6476235B2 (en) * | 2001-01-09 | 2002-11-05 | Warner-Lambert Company | Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| WO2002057229A1 (en) * | 2001-01-19 | 2002-07-25 | Biocon India Limited | FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN) |
| BR0210666A (pt) | 2001-06-29 | 2004-10-05 | Warner Lambert Co | Formas cristalinas do sal de cálcio do ácido [r-(r*,r*)]-2-(4-fluorofenil)-beta, delta-dihidróxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)c arbonil]-1h-pirrol-1-heptanóico (2:1) (atorvastatina) |
| HUP0401014A2 (hu) * | 2001-07-06 | 2004-08-30 | Teva Pharmaceutical Industries Ltd. | Eljárás 7-amino-szin-3,5-dihidroxi-heptánsavszármazékok előállítására, 6-ciano-szin-3,5-dihidroxi-hexánsav származékokon keresztül |
| AU2002241235B2 (en) * | 2002-02-25 | 2009-04-23 | Biocon Limited | Novel boronate esters |
| GB0211716D0 (en) | 2002-05-22 | 2002-07-03 | Phoenix Chemicals Ltd | Process |
| EP1534704B1 (en) | 2002-08-06 | 2007-08-01 | Warner-Lambert Company LLC | Process for preparing 5-(4-fluorophenyl)-1-¬2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl|-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| ATE394384T1 (de) * | 2002-09-18 | 2008-05-15 | Sk Holdings Co Ltd | Kontinuierliches verfahren zur herstellung von optisch reinem (s)-beta hydroxy- gamma- butyrolacton |
| WO2004027075A2 (en) * | 2002-09-20 | 2004-04-01 | Diversa Corporation | Chemoenzymatic methods for the synthesis of statins and stain intermediates |
| US6713639B1 (en) | 2002-10-28 | 2004-03-30 | Council Of Scientific And Industrial Research | Process for preparing enantiomerically pure (S)-3-hydroxy-gamma-butyrolactone |
| RU2337905C2 (ru) * | 2003-04-14 | 2008-11-10 | Уорнер-Ламберт Компани Ллс | Способ получения фениламида 5-(4-фторфенил)-1-[2-((2r,4r)-4-гидрокси-6-оксотетрагидропиран-2-ил)этил]-2-изопропил-4-фенил-1h-пиррол-3-карбоновой кислоты |
| EP1631533B1 (en) * | 2003-04-22 | 2009-03-11 | Biocon Limited | Novel process for stereoselective reduction of beta-ketoesters |
| US7790197B2 (en) * | 2003-06-09 | 2010-09-07 | Warner-Lambert Company Llc | Pharmaceutical compositions of atorvastatin |
| US7655692B2 (en) * | 2003-06-12 | 2010-02-02 | Pfizer Inc. | Process for forming amorphous atorvastatin |
| US20050271717A1 (en) * | 2003-06-12 | 2005-12-08 | Alfred Berchielli | Pharmaceutical compositions of atorvastatin |
| US20040253305A1 (en) * | 2003-06-12 | 2004-12-16 | Luner Paul E. | Pharmaceutical compositions of atorvastatin |
| BRPI0414457A (pt) * | 2003-09-17 | 2006-11-14 | Warner Lambert Co | formas cristalinas do ácido [r-(r*,r*)]-2-(4-fluorofenil)-beta, delta-dihidróxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)-c arbonil]-1h-pirrol-1-heptanóico |
| WO2005068642A2 (en) | 2003-10-01 | 2005-07-28 | Board Of Trustees Operating Michigan State University | Bacterial synthesis of 1,2,4-butanetriol enantiomers |
| CN1960972A (zh) * | 2004-04-16 | 2007-05-09 | 辉瑞产品公司 | 用于形成无定形阿托伐它汀钙的方法 |
| US7875731B2 (en) | 2004-05-05 | 2011-01-25 | Pfizer Inc. | Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid |
| CA2701710C (en) * | 2004-07-20 | 2013-08-27 | Warner-Lambert Company Llc | Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| US7939675B2 (en) * | 2004-10-28 | 2011-05-10 | Pfizer, Inc. | Process for forming amorphous atorvastatin |
| US20090088465A1 (en) * | 2004-12-02 | 2009-04-02 | Stephen Craig Dyar | Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same |
| WO2006129649A1 (ja) * | 2005-05-31 | 2006-12-07 | Kowa Co., Ltd. | 光学活性ｐｐａｒ活性化化合物及びその製造中間体の製造法 |
| CA2547216A1 (en) * | 2005-09-21 | 2007-03-21 | Renuka D. Reddy | Process for annealing amorphous atorvastatin |
| US8084488B2 (en) * | 2005-11-21 | 2011-12-27 | Pfizer Inc. | Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium |
| US20110165641A1 (en) * | 2006-03-31 | 2011-07-07 | The Board Of Trustees Of Michigan State University | Synthesis of 1,2,4-Butanetriol Enantiomers from Carbohydrates |
| WO2008091288A2 (en) * | 2006-07-19 | 2008-07-31 | Board Of Trustees Of Michigan State University | Microbial synthesis of d-1,2,4-butanetriol |
| KR100850558B1 (ko) | 2008-01-02 | 2008-08-06 | 조동옥 | 아토르바스타틴의 효율적인 제조방법 |
| JP2009256316A (ja) | 2008-03-28 | 2009-11-05 | Daicel Chem Ind Ltd | β−ヒドロキシ−γ−ブチロラクトンの製造方法 |
| CN101337906B (zh) * | 2008-08-15 | 2012-06-27 | 河南豫辰精细化工有限公司 | 一种4-甲基-3-氧代-n-苯基戊酰胺的制备方法 |
| EP2327682A1 (en) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
| EP2373609B1 (en) | 2008-12-19 | 2013-10-16 | KRKA, D.D., Novo Mesto | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
| CN103702982A (zh) | 2011-07-01 | 2014-04-02 | 中化帝斯曼制药有限公司荷兰公司 | 阿托伐他汀半钙的超细晶体 |
| CN106397241A (zh) * | 2016-08-23 | 2017-02-15 | 杨锋 | 一种4‑甲基‑3‑氧代‑n‑苯基戊酰胺的绿色环保后处理方法 |
| CN106588689A (zh) * | 2016-12-15 | 2017-04-26 | 河南豫辰药业股份有限公司 | 一种从结晶母液废液中回收阿托伐他汀中间体m4的方法 |
| CN112939901B (zh) * | 2021-02-09 | 2023-05-09 | 中国科学院福建物质结构研究所 | 一种α-羟基-γ-丁内酯的制备方法 |
| CN114195670B (zh) * | 2021-12-31 | 2024-03-15 | 河南豫辰药业股份有限公司 | 一种阿托伐他汀母核m4的精制方法 |
| CN117447350B (zh) * | 2023-10-26 | 2026-02-13 | 河南豫辰药业股份有限公司 | 一种阿托伐他汀m4有机废物综合再利用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2710688B2 (ja) * | 1990-10-09 | 1998-02-10 | 鐘淵化学工業株式会社 | ４―ブロモ―３―ヒドロキシ酪酸エステル誘導体の製造法 |
| CA2049536C (en) * | 1991-05-13 | 1999-07-06 | Rawle I. Hollingsworth | Process for the preparation of 3,4-dihydroxybutanoic acid and salts thereof |
| JP3351563B2 (ja) * | 1992-12-03 | 2002-11-25 | 鐘淵化学工業株式会社 | ３−ヒドロキシ酪酸誘導体の製造法 |
| DE69711391T2 (de) * | 1996-07-29 | 2002-11-07 | Warner-Lambert Co., Morris Plains | Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern |
-
1997
- 1997-07-01 DE DE69711391T patent/DE69711391T2/de not_active Expired - Fee Related
- 1997-07-01 DK DK97931557T patent/DK0915866T3/da active
- 1997-07-01 US US09/230,397 patent/US5998633A/en not_active Expired - Fee Related
- 1997-07-01 AT AT97931557T patent/ATE215078T1/de not_active IP Right Cessation
- 1997-07-01 IL IL12705897A patent/IL127058A/en not_active IP Right Cessation
- 1997-07-01 EP EP97931557A patent/EP0915866B1/en not_active Expired - Lifetime
- 1997-07-01 TR TR1999/00191T patent/TR199900191T2/xx unknown
- 1997-07-01 CN CN97195996A patent/CN1093126C/zh not_active Expired - Fee Related
- 1997-07-01 HU HU9904348A patent/HU226465B1/hu not_active IP Right Cessation
- 1997-07-01 JP JP10508813A patent/JP2000515882A/ja not_active Ceased
- 1997-07-01 AU AU35154/97A patent/AU3515497A/en not_active Abandoned
- 1997-07-01 KR KR10-1999-7000721A patent/KR100447370B1/ko not_active Expired - Fee Related
- 1997-07-01 PT PT97931557T patent/PT915866E/pt unknown
- 1997-07-01 ES ES97931557T patent/ES2176756T3/es not_active Expired - Lifetime
- 1997-07-01 WO PCT/US1997/011654 patent/WO1998004543A1/en not_active Ceased
- 1997-07-28 ZA ZA9706705A patent/ZA976705B/xx unknown
- 1997-07-28 CO CO97042973A patent/CO4950542A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1020728A1 (en) | 2000-05-19 |
| CN1093126C (zh) | 2002-10-23 |
| KR100447370B1 (ko) | 2004-09-08 |
| HUP9904348A3 (en) | 2004-03-01 |
| ES2176756T3 (es) | 2002-12-01 |
| US5998633A (en) | 1999-12-07 |
| IL127058A (en) | 2001-07-24 |
| DE69711391T2 (de) | 2002-11-07 |
| KR20000029648A (ko) | 2000-05-25 |
| WO1998004543A1 (en) | 1998-02-05 |
| PT915866E (pt) | 2002-07-31 |
| DK0915866T3 (da) | 2002-06-10 |
| CN1223647A (zh) | 1999-07-21 |
| DE69711391D1 (de) | 2002-05-02 |
| JP2000515882A (ja) | 2000-11-28 |
| AU3515497A (en) | 1998-02-20 |
| HU226465B1 (en) | 2008-12-29 |
| HUP9904348A2 (hu) | 2000-04-28 |
| IL127058A0 (en) | 1999-09-22 |
| CO4950542A1 (es) | 2000-09-01 |
| ATE215078T1 (de) | 2002-04-15 |
| EP0915866B1 (en) | 2002-03-27 |
| EP0915866A1 (en) | 1999-05-19 |
| ZA976705B (en) | 1998-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199900191T2 (xx) | (S)-3,4-Dihidroksibutirik asitin korumal� esterlerinin sentezi i�in geli�tirilmi� proses. | |
| NO975387D0 (no) | Fremgangsmåte for fremstilling av 3-haloalkyl-1H-pyrazoler | |
| HUP0100845A3 (en) | Hydroxamid acid derivatives as matrix metalloprotease(mmp) inhibitors, process for producing them and pharmaceutical compositions containing them | |
| TR199600792A2 (tr) | Dihaloazolopirimidinlerin hazirlanmasina yönelik proses. | |
| ID19926A (id) | Proses untuk produksi asam tereftalat murni | |
| ID21654A (id) | Proses derivatisasi selektif taksana | |
| HUP9901079A3 (en) | 5- and 6-membered cyclic compounds containing nitrogenatom, pharmaceutical compositions containing them, their use for producing pharmaceutical compositions and their producing | |
| AU5130299A (en) | Wrist-mounted i.v. administration set | |
| TR199800077T1 (xx) | Kontroll� ��z�len paroksetin terkipleri. | |
| WO1995001168A3 (de) | Pharmazeutische zubereitungen, die einen wirkstoff mit modifizierten amidingruppen enthält | |
| MX9800408A (es) | Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
| HUP0002921A3 (en) | Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them | |
| HUP0002853A3 (en) | 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them | |
| TR200000006T2 (tr) | Yeni formülasyon. | |
| NZ325235A (en) | New phenylamidine derivatives, a process for preparing the same and their use as medicaments | |
| MXPA03010251A (es) | Proceso para la preparacion de ribavirina. | |
| ID16192A (id) | Proses pembuatan asam-asam .alpha., beta-karboksilat organik tak jenuh | |
| NO960826L (no) | Anvendelse av enzymer fra krill i forstoffer | |
| TR200000624T2 (tr) | Bir enzimin etkinliğinin arttırılması ile ilgili bir yöntem. | |
| ID29219A (id) | (1-fenasi-3-fenil-3-piperidiletil): turunan-turunan piperidin, proses untuk memperolehnya dan komposisi-komposisi farmasi | |
| ES542835A0 (es) | Procedimiento de preparar un antigeno relacionado con el ligamento glicosidico,derivado de celulas de cancer. | |
| CA2294158A1 (en) | Natural antitumor or antiviral substances and use of the same | |
| IL148161A0 (en) | Process for the preparation of 2-cyanopyridines | |
| TR200003351T2 (tr) | Paroksetin içeren yeni formülasyon | |
| PT1064265E (pt) | Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona |